Clinical Trial Update: Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study [Phase 2, Phase 3]

View source ↗

Summary

Apatinib is being studied in combination with transarterial chemoembolization (TACE) for hepatocellular carcinoma with pulmonary metastasis, in Phase 2 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Pulmonary Metastasis

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Hepatocellular Carcinoma, Pulmonary Metastasis | Phase 2, Phase 3 | Status: UNKNOWN